The clinical studies have shown that secnidazole is characterised by very good tolerance and to date, no adverse reactions have been reported.The following side-effectsmay be observed with secnidazole as with all nitroimidazole derivatives and are rarely serious.
Most frequently :
Gastrointestinal disturbances, nausea, epigastric pain, metallic taste, glossitis, stomatitis.
Occasionally :
Urticaria,moderate leukopenia which is reversible on treatment withdrawal.
Rarely :
Vertigo, ataxia and motor incoordination, paresthesia, peripheral neuropathy.
With SEZOL DS Gastrointestinal disorders (nausea, vomiting, epigastric pain) have been reported in very rare cases.